Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-8,100
Closed -$292K 1345
2018
Q2
$292K Hold
8,100
﹤0.01% 1236
2018
Q1
$220K Hold
8,100
﹤0.01% 1311
2017
Q4
$209K Buy
+8,100
New +$213K ﹤0.01% 1303
2017
Q3
Sell
-29,662
Closed -$641K 1318
2017
Q2
$641K Hold
29,662
﹤0.01% 1018
2017
Q1
$632K Sell
29,662
-60,538
-67% -$1.34M ﹤0.01% 1033
2016
Q4
$2.02M Buy
90,200
+8,579
+11% +$175K 0.01% 761
2016
Q3
$1.52M Buy
81,621
+77,521
+1,891% +$1.46M 0.01% 821
2016
Q2
$73K Buy
+4,100
New +$70.8K ﹤0.01% 1271

Other funds holding CTS

Axa's CTS Position: Q3 2018 in Review

Axa sold out of CTS Corp (CTS) in Q3 2018, closing a stake of 8,100 shares — an estimated $292K sold.

Axa first reported a position in CTS in Q2 2016 and held it in 8 quarters. The position peaked at $2.02M in Q4 2016. 146 funds tracked by Wall St. Rank hold CTS as of Q3 2018.

  • Axa reported no remaining CTS Corp position as of Q3 2018 after selling out during the quarter.
  • Axa sold 8,100 CTS Corp shares in Q3 2018, an estimated $292K.
  • Axa first reported a position in CTS Corp in Q2 2016 and held it in 8 quarters.
  • Axa's CTS Corp position peaked at $2.02M in Q4 2016.
  • 146 funds tracked by Wall St. Rank held CTS Corp as of Q3 2018.

Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.